Notice of Results

RNS Number : 9445H

Venn Life Sciences Holdings PLC

24 August 2016

 

24 August 2016

Venn Life Sciences Holdings Plc

("Venn" or the "Company")

Notice of results

Investor results presentation

Venn Life Sciences (AIM: VENN), a growing Contract Research Organisation (CRO) providing drug development, clinical trial management and resourcing solutions to pharmaceutical, biotechnology and medical device clients, announces that it will release its interim results for the six months ended 30 June 2016 on Wednesday 28 September 2016.

Analyst briefing

Tony Richardson, Chief Executive Officer and Jonathan Hartshorn Chief Financial Officer will be hosting a briefing for analysts on Wednesday 28 September 2016 at 10.30am at the offices of Walbrook PR, 4 Lombard St., London EC3V 9HD.

Investor briefing

The management team will also be presenting the Company's financial and operational results for investors on the evening of Wednesday 28 September 2016. The event is open to all investors and will be held at the Black Bar, upstairs at Rocket Bar 6 Adam's Court, Old Broad St, London EC2N 1DX.

To register to attend the analyst briefing or investor briefing, please contact Walbrook PR (details below).

Walbrook PR Limited	Tel: [phone] or [e-mail]
Anna Dunphy		Mob: [phone]
Lianne Cawthorne		Mob: [phone]

 

END

 

 

NOREXLFLQVFLBBQ